A prospective observational cohort study (NCT04300088) explored the impact of HLA-G expression level on the efficacy of tumor immunotherapies (anti-PD-1/PD-L1 therapy and/or anti-CTLA-4 therapy), providing a strong rationale for demonstrating the relationship between HLA-G and tumor resistance to immunotherapy. This evidence concerns the gene CD274 and neoplasm.